nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Vismodegib—skin cancer	0.164	0.221	CbGbCtD
Guanfacine—CYP2C9—Vismodegib—skin cancer	0.137	0.184	CbGbCtD
Guanfacine—CYP3A4—Temozolomide—skin cancer	0.115	0.154	CbGbCtD
Guanfacine—CYP3A4—Imiquimod—skin cancer	0.115	0.154	CbGbCtD
Guanfacine—CYP3A4—Vismodegib—skin cancer	0.0794	0.107	CbGbCtD
Guanfacine—CYP3A4—Vemurafenib—skin cancer	0.0628	0.0846	CbGbCtD
Guanfacine—CYP2C9—Fluorouracil—skin cancer	0.0485	0.0654	CbGbCtD
Guanfacine—CYP3A4—Docetaxel—skin cancer	0.0215	0.029	CbGbCtD
Guanfacine—NISCH—Paclitaxel—Docetaxel—skin cancer	0.00878	1	CbGdCrCtD
Guanfacine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00125	0.00502	CcSEcCtD
Guanfacine—Immune system disorder—Imiquimod—skin cancer	0.00123	0.00494	CcSEcCtD
Guanfacine—Purpura—Temozolomide—skin cancer	0.00122	0.00491	CcSEcCtD
Guanfacine—Liver function test abnormal—Dactinomycin—skin cancer	0.0012	0.00483	CcSEcCtD
Guanfacine—Alopecia—Imiquimod—skin cancer	0.0012	0.00483	CcSEcCtD
Guanfacine—Arthralgia—Vemurafenib—skin cancer	0.00118	0.00475	CcSEcCtD
Guanfacine—Myalgia—Vemurafenib—skin cancer	0.00118	0.00475	CcSEcCtD
Guanfacine—Vomiting—Vismodegib—skin cancer	0.00117	0.00468	CcSEcCtD
Guanfacine—Affect lability—Temozolomide—skin cancer	0.00116	0.00466	CcSEcCtD
Guanfacine—Rash—Vismodegib—skin cancer	0.00116	0.00465	CcSEcCtD
Guanfacine—Amnesia—Fluorouracil—skin cancer	0.00116	0.00464	CcSEcCtD
Guanfacine—Dermatitis—Vismodegib—skin cancer	0.00116	0.00464	CcSEcCtD
Guanfacine—Dysphagia—Dactinomycin—skin cancer	0.00113	0.00452	CcSEcCtD
Guanfacine—Lethargy—Fluorouracil—skin cancer	0.00111	0.00445	CcSEcCtD
Guanfacine—Ill-defined disorder—Imiquimod—skin cancer	0.0011	0.00441	CcSEcCtD
Guanfacine—Nausea—Vismodegib—skin cancer	0.00109	0.00438	CcSEcCtD
Guanfacine—Agitation—Imiquimod—skin cancer	0.00109	0.00437	CcSEcCtD
Guanfacine—Malaise—Imiquimod—skin cancer	0.00107	0.00429	CcSEcCtD
Guanfacine—Syncope—Imiquimod—skin cancer	0.00106	0.00427	CcSEcCtD
Guanfacine—Acute coronary syndrome—Bleomycin—skin cancer	0.00106	0.00426	CcSEcCtD
Guanfacine—Hypotension—Vemurafenib—skin cancer	0.00106	0.00425	CcSEcCtD
Guanfacine—Myocardial infarction—Bleomycin—skin cancer	0.00106	0.00424	CcSEcCtD
Guanfacine—Palpitations—Imiquimod—skin cancer	0.00105	0.0042	CcSEcCtD
Guanfacine—Loss of consciousness—Imiquimod—skin cancer	0.00104	0.00418	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00104	0.00417	CcSEcCtD
Guanfacine—Irritability—Fluorouracil—skin cancer	0.00104	0.00416	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00103	0.00415	CcSEcCtD
Guanfacine—Skin exfoliation—Docetaxel—skin cancer	0.00103	0.00414	CcSEcCtD
Guanfacine—Convulsion—Imiquimod—skin cancer	0.00103	0.00412	CcSEcCtD
Guanfacine—Hypertension—Imiquimod—skin cancer	0.00102	0.00411	CcSEcCtD
Guanfacine—Dysphagia—Temozolomide—skin cancer	0.00102	0.00409	CcSEcCtD
Guanfacine—Arthralgia—Imiquimod—skin cancer	0.00101	0.00405	CcSEcCtD
Guanfacine—Chest pain—Imiquimod—skin cancer	0.00101	0.00405	CcSEcCtD
Guanfacine—Myalgia—Imiquimod—skin cancer	0.00101	0.00405	CcSEcCtD
Guanfacine—Anxiety—Imiquimod—skin cancer	0.00101	0.00404	CcSEcCtD
Guanfacine—Discomfort—Imiquimod—skin cancer	0.000997	0.004	CcSEcCtD
Guanfacine—Dry mouth—Imiquimod—skin cancer	0.000986	0.00396	CcSEcCtD
Guanfacine—Decreased appetite—Vemurafenib—skin cancer	0.000986	0.00396	CcSEcCtD
Guanfacine—Fatigue—Vemurafenib—skin cancer	0.000978	0.00392	CcSEcCtD
Guanfacine—Constipation—Vemurafenib—skin cancer	0.00097	0.00389	CcSEcCtD
Guanfacine—Oedema—Imiquimod—skin cancer	0.000967	0.00388	CcSEcCtD
Guanfacine—Shock—Imiquimod—skin cancer	0.000951	0.00382	CcSEcCtD
Guanfacine—Tachycardia—Imiquimod—skin cancer	0.000944	0.00379	CcSEcCtD
Guanfacine—Pollakiuria—Temozolomide—skin cancer	0.000941	0.00378	CcSEcCtD
Guanfacine—Dysphagia—Fluorouracil—skin cancer	0.000939	0.00377	CcSEcCtD
Guanfacine—Erectile dysfunction—Temozolomide—skin cancer	0.000938	0.00377	CcSEcCtD
Guanfacine—Hyperhidrosis—Imiquimod—skin cancer	0.000935	0.00375	CcSEcCtD
Guanfacine—Weight increased—Temozolomide—skin cancer	0.000927	0.00372	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000881	0.00354	CcSEcCtD
Guanfacine—Insomnia—Imiquimod—skin cancer	0.000875	0.00351	CcSEcCtD
Guanfacine—Paraesthesia—Imiquimod—skin cancer	0.000868	0.00349	CcSEcCtD
Guanfacine—Cardiac failure congestive—Docetaxel—skin cancer	0.000865	0.00347	CcSEcCtD
Guanfacine—Dyspnoea—Imiquimod—skin cancer	0.000862	0.00346	CcSEcCtD
Guanfacine—Somnolence—Imiquimod—skin cancer	0.00086	0.00345	CcSEcCtD
Guanfacine—Alopecia—Bleomycin—skin cancer	0.000854	0.00343	CcSEcCtD
Guanfacine—Dyspepsia—Imiquimod—skin cancer	0.000851	0.00342	CcSEcCtD
Guanfacine—Decreased appetite—Imiquimod—skin cancer	0.000841	0.00337	CcSEcCtD
Guanfacine—Hypersensitivity—Vemurafenib—skin cancer	0.000835	0.00335	CcSEcCtD
Guanfacine—Fatigue—Imiquimod—skin cancer	0.000834	0.00335	CcSEcCtD
Guanfacine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000825	0.00331	CcSEcCtD
Guanfacine—Myocardial infarction—Fluorouracil—skin cancer	0.000821	0.00329	CcSEcCtD
Guanfacine—Conjunctivitis—Fluorouracil—skin cancer	0.000814	0.00327	CcSEcCtD
Guanfacine—Asthenia—Vemurafenib—skin cancer	0.000813	0.00327	CcSEcCtD
Guanfacine—Hallucination—Temozolomide—skin cancer	0.000812	0.00326	CcSEcCtD
Guanfacine—Pruritus—Vemurafenib—skin cancer	0.000802	0.00322	CcSEcCtD
Guanfacine—Lethargy—Docetaxel—skin cancer	0.0008	0.00321	CcSEcCtD
Guanfacine—Alopecia—Dactinomycin—skin cancer	0.000797	0.0032	CcSEcCtD
Guanfacine—Feeling abnormal—Imiquimod—skin cancer	0.000797	0.0032	CcSEcCtD
Guanfacine—Gastrointestinal pain—Imiquimod—skin cancer	0.000791	0.00317	CcSEcCtD
Guanfacine—Visual impairment—Temozolomide—skin cancer	0.000786	0.00316	CcSEcCtD
Guanfacine—Pain in extremity—Docetaxel—skin cancer	0.000784	0.00315	CcSEcCtD
Guanfacine—Ill-defined disorder—Bleomycin—skin cancer	0.000781	0.00314	CcSEcCtD
Guanfacine—Diarrhoea—Vemurafenib—skin cancer	0.000776	0.00311	CcSEcCtD
Guanfacine—Abdominal pain—Imiquimod—skin cancer	0.000764	0.00307	CcSEcCtD
Guanfacine—Eye disorder—Temozolomide—skin cancer	0.000762	0.00306	CcSEcCtD
Guanfacine—Tinnitus—Temozolomide—skin cancer	0.00076	0.00305	CcSEcCtD
Guanfacine—Malaise—Bleomycin—skin cancer	0.000759	0.00305	CcSEcCtD
Guanfacine—Rhinitis—Fluorouracil—skin cancer	0.000753	0.00302	CcSEcCtD
Guanfacine—Dizziness—Vemurafenib—skin cancer	0.00075	0.00301	CcSEcCtD
Guanfacine—Immune system disorder—Temozolomide—skin cancer	0.000737	0.00296	CcSEcCtD
Guanfacine—Ill-defined disorder—Dactinomycin—skin cancer	0.000728	0.00292	CcSEcCtD
Guanfacine—Liver function test abnormal—Docetaxel—skin cancer	0.000724	0.00291	CcSEcCtD
Guanfacine—Vomiting—Vemurafenib—skin cancer	0.000721	0.00289	CcSEcCtD
Guanfacine—Alopecia—Temozolomide—skin cancer	0.000721	0.00289	CcSEcCtD
Guanfacine—Chest pain—Bleomycin—skin cancer	0.000717	0.00288	CcSEcCtD
Guanfacine—Myalgia—Bleomycin—skin cancer	0.000717	0.00288	CcSEcCtD
Guanfacine—Orthostatic hypotension—Docetaxel—skin cancer	0.000716	0.00288	CcSEcCtD
Guanfacine—Abdominal pain upper—Docetaxel—skin cancer	0.000716	0.00288	CcSEcCtD
Guanfacine—Rash—Vemurafenib—skin cancer	0.000715	0.00287	CcSEcCtD
Guanfacine—Dermatitis—Vemurafenib—skin cancer	0.000714	0.00287	CcSEcCtD
Guanfacine—Hypersensitivity—Imiquimod—skin cancer	0.000712	0.00286	CcSEcCtD
Guanfacine—Headache—Vemurafenib—skin cancer	0.00071	0.00285	CcSEcCtD
Guanfacine—Discomfort—Bleomycin—skin cancer	0.000708	0.00284	CcSEcCtD
Guanfacine—Malaise—Dactinomycin—skin cancer	0.000708	0.00284	CcSEcCtD
Guanfacine—Dysgeusia—Temozolomide—skin cancer	0.000695	0.00279	CcSEcCtD
Guanfacine—Asthenia—Imiquimod—skin cancer	0.000694	0.00279	CcSEcCtD
Guanfacine—Confusional state—Bleomycin—skin cancer	0.000693	0.00278	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000692	0.00278	CcSEcCtD
Guanfacine—Oedema—Bleomycin—skin cancer	0.000687	0.00276	CcSEcCtD
Guanfacine—Pruritus—Imiquimod—skin cancer	0.000684	0.00275	CcSEcCtD
Guanfacine—Dysphagia—Docetaxel—skin cancer	0.000678	0.00272	CcSEcCtD
Guanfacine—Nausea—Vemurafenib—skin cancer	0.000673	0.0027	CcSEcCtD
Guanfacine—Vision blurred—Temozolomide—skin cancer	0.000669	0.00269	CcSEcCtD
Guanfacine—Myalgia—Dactinomycin—skin cancer	0.000668	0.00268	CcSEcCtD
Guanfacine—Tremor—Temozolomide—skin cancer	0.000665	0.00267	CcSEcCtD
Guanfacine—Alopecia—Fluorouracil—skin cancer	0.000664	0.00267	CcSEcCtD
Guanfacine—Diarrhoea—Imiquimod—skin cancer	0.000662	0.00266	CcSEcCtD
Guanfacine—Discomfort—Dactinomycin—skin cancer	0.00066	0.00265	CcSEcCtD
Guanfacine—Ill-defined disorder—Temozolomide—skin cancer	0.000659	0.00264	CcSEcCtD
Guanfacine—Agitation—Temozolomide—skin cancer	0.000652	0.00262	CcSEcCtD
Guanfacine—Hypotension—Bleomycin—skin cancer	0.000642	0.00258	CcSEcCtD
Guanfacine—Oedema—Dactinomycin—skin cancer	0.000641	0.00257	CcSEcCtD
Guanfacine—Malaise—Temozolomide—skin cancer	0.00064	0.00257	CcSEcCtD
Guanfacine—Dizziness—Imiquimod—skin cancer	0.000639	0.00257	CcSEcCtD
Guanfacine—Vertigo—Temozolomide—skin cancer	0.000638	0.00256	CcSEcCtD
Guanfacine—Palpitations—Temozolomide—skin cancer	0.000627	0.00252	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000626	0.00251	CcSEcCtD
Guanfacine—Paraesthesia—Bleomycin—skin cancer	0.000617	0.00248	CcSEcCtD
Guanfacine—Weight increased—Docetaxel—skin cancer	0.000617	0.00248	CcSEcCtD
Guanfacine—Vision blurred—Fluorouracil—skin cancer	0.000617	0.00248	CcSEcCtD
Guanfacine—Convulsion—Temozolomide—skin cancer	0.000615	0.00247	CcSEcCtD
Guanfacine—Vomiting—Imiquimod—skin cancer	0.000615	0.00247	CcSEcCtD
Guanfacine—Hypertension—Temozolomide—skin cancer	0.000613	0.00246	CcSEcCtD
Guanfacine—Dyspnoea—Bleomycin—skin cancer	0.000612	0.00246	CcSEcCtD
Guanfacine—Rash—Imiquimod—skin cancer	0.00061	0.00245	CcSEcCtD
Guanfacine—Dermatitis—Imiquimod—skin cancer	0.000609	0.00245	CcSEcCtD
Guanfacine—Headache—Imiquimod—skin cancer	0.000606	0.00243	CcSEcCtD
Guanfacine—Arthralgia—Temozolomide—skin cancer	0.000604	0.00243	CcSEcCtD
Guanfacine—Myalgia—Temozolomide—skin cancer	0.000604	0.00243	CcSEcCtD
Guanfacine—Anxiety—Temozolomide—skin cancer	0.000602	0.00242	CcSEcCtD
Guanfacine—Discomfort—Temozolomide—skin cancer	0.000597	0.0024	CcSEcCtD
Guanfacine—Decreased appetite—Bleomycin—skin cancer	0.000597	0.0024	CcSEcCtD
Guanfacine—Acute coronary syndrome—Docetaxel—skin cancer	0.000596	0.00239	CcSEcCtD
Guanfacine—Myocardial infarction—Docetaxel—skin cancer	0.000592	0.00238	CcSEcCtD
Guanfacine—Dry mouth—Temozolomide—skin cancer	0.000591	0.00237	CcSEcCtD
Guanfacine—Conjunctivitis—Docetaxel—skin cancer	0.000587	0.00236	CcSEcCtD
Guanfacine—Confusional state—Temozolomide—skin cancer	0.000584	0.00235	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000584	0.00234	CcSEcCtD
Guanfacine—Oedema—Temozolomide—skin cancer	0.000579	0.00233	CcSEcCtD
Guanfacine—Nausea—Imiquimod—skin cancer	0.000574	0.00231	CcSEcCtD
Guanfacine—Convulsion—Fluorouracil—skin cancer	0.000567	0.00228	CcSEcCtD
Guanfacine—Feeling abnormal—Bleomycin—skin cancer	0.000566	0.00227	CcSEcCtD
Guanfacine—Hyperhidrosis—Temozolomide—skin cancer	0.00056	0.00225	CcSEcCtD
Guanfacine—Myalgia—Fluorouracil—skin cancer	0.000557	0.00224	CcSEcCtD
Guanfacine—Chest pain—Fluorouracil—skin cancer	0.000557	0.00224	CcSEcCtD
Guanfacine—Decreased appetite—Dactinomycin—skin cancer	0.000557	0.00224	CcSEcCtD
Guanfacine—Fatigue—Dactinomycin—skin cancer	0.000552	0.00222	CcSEcCtD
Guanfacine—Discomfort—Fluorouracil—skin cancer	0.00055	0.00221	CcSEcCtD
Guanfacine—Rhinitis—Docetaxel—skin cancer	0.000544	0.00218	CcSEcCtD
Guanfacine—Confusional state—Fluorouracil—skin cancer	0.000538	0.00216	CcSEcCtD
Guanfacine—Oedema—Fluorouracil—skin cancer	0.000534	0.00214	CcSEcCtD
Guanfacine—Feeling abnormal—Dactinomycin—skin cancer	0.000528	0.00212	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000528	0.00212	CcSEcCtD
Guanfacine—Insomnia—Temozolomide—skin cancer	0.000524	0.0021	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000524	0.0021	CcSEcCtD
Guanfacine—Visual impairment—Docetaxel—skin cancer	0.000523	0.0021	CcSEcCtD
Guanfacine—Tachycardia—Fluorouracil—skin cancer	0.000521	0.00209	CcSEcCtD
Guanfacine—Paraesthesia—Temozolomide—skin cancer	0.00052	0.00209	CcSEcCtD
Guanfacine—Dyspnoea—Temozolomide—skin cancer	0.000517	0.00207	CcSEcCtD
Guanfacine—Somnolence—Temozolomide—skin cancer	0.000515	0.00207	CcSEcCtD
Guanfacine—Dyspepsia—Temozolomide—skin cancer	0.00051	0.00205	CcSEcCtD
Guanfacine—Eye disorder—Docetaxel—skin cancer	0.000507	0.00204	CcSEcCtD
Guanfacine—Abdominal pain—Dactinomycin—skin cancer	0.000506	0.00203	CcSEcCtD
Guanfacine—Hypersensitivity—Bleomycin—skin cancer	0.000506	0.00203	CcSEcCtD
Guanfacine—Decreased appetite—Temozolomide—skin cancer	0.000504	0.00202	CcSEcCtD
Guanfacine—Fatigue—Temozolomide—skin cancer	0.0005	0.00201	CcSEcCtD
Guanfacine—Hypotension—Fluorouracil—skin cancer	0.000499	0.002	CcSEcCtD
Guanfacine—Constipation—Temozolomide—skin cancer	0.000496	0.00199	CcSEcCtD
Guanfacine—Asthenia—Bleomycin—skin cancer	0.000493	0.00198	CcSEcCtD
Guanfacine—Immune system disorder—Docetaxel—skin cancer	0.00049	0.00197	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000486	0.00195	CcSEcCtD
Guanfacine—Pruritus—Bleomycin—skin cancer	0.000486	0.00195	CcSEcCtD
Guanfacine—Insomnia—Fluorouracil—skin cancer	0.000483	0.00194	CcSEcCtD
Guanfacine—Paraesthesia—Fluorouracil—skin cancer	0.000479	0.00192	CcSEcCtD
Guanfacine—Alopecia—Docetaxel—skin cancer	0.000479	0.00192	CcSEcCtD
Guanfacine—Feeling abnormal—Temozolomide—skin cancer	0.000478	0.00192	CcSEcCtD
Guanfacine—Dyspnoea—Fluorouracil—skin cancer	0.000476	0.00191	CcSEcCtD
Guanfacine—Somnolence—Fluorouracil—skin cancer	0.000475	0.00191	CcSEcCtD
Guanfacine—Gastrointestinal pain—Temozolomide—skin cancer	0.000474	0.0019	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—skin cancer	0.000472	0.0019	CcSEcCtD
Guanfacine—Dyspepsia—Fluorouracil—skin cancer	0.00047	0.00189	CcSEcCtD
Guanfacine—Decreased appetite—Fluorouracil—skin cancer	0.000464	0.00186	CcSEcCtD
Guanfacine—Dysgeusia—Docetaxel—skin cancer	0.000462	0.00186	CcSEcCtD
Guanfacine—Asthenia—Dactinomycin—skin cancer	0.00046	0.00185	CcSEcCtD
Guanfacine—Abdominal pain—Temozolomide—skin cancer	0.000458	0.00184	CcSEcCtD
Guanfacine—Muscle spasms—Docetaxel—skin cancer	0.000454	0.00182	CcSEcCtD
Guanfacine—Feeling abnormal—Fluorouracil—skin cancer	0.00044	0.00177	CcSEcCtD
Guanfacine—Diarrhoea—Dactinomycin—skin cancer	0.000438	0.00176	CcSEcCtD
Guanfacine—Vomiting—Bleomycin—skin cancer	0.000437	0.00175	CcSEcCtD
Guanfacine—Rash—Bleomycin—skin cancer	0.000433	0.00174	CcSEcCtD
Guanfacine—Dermatitis—Bleomycin—skin cancer	0.000433	0.00174	CcSEcCtD
Guanfacine—Hypersensitivity—Temozolomide—skin cancer	0.000427	0.00171	CcSEcCtD
Guanfacine—Syncope—Docetaxel—skin cancer	0.000423	0.0017	CcSEcCtD
Guanfacine—Palpitations—Docetaxel—skin cancer	0.000417	0.00168	CcSEcCtD
Guanfacine—Asthenia—Temozolomide—skin cancer	0.000416	0.00167	CcSEcCtD
Guanfacine—Loss of consciousness—Docetaxel—skin cancer	0.000415	0.00167	CcSEcCtD
Guanfacine—Pruritus—Temozolomide—skin cancer	0.00041	0.00165	CcSEcCtD
Guanfacine—Convulsion—Docetaxel—skin cancer	0.000409	0.00164	CcSEcCtD
Guanfacine—Nausea—Bleomycin—skin cancer	0.000408	0.00164	CcSEcCtD
Guanfacine—Hypertension—Docetaxel—skin cancer	0.000408	0.00164	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—skin cancer	0.000407	0.00164	CcSEcCtD
Guanfacine—Rash—Dactinomycin—skin cancer	0.000404	0.00162	CcSEcCtD
Guanfacine—Myalgia—Docetaxel—skin cancer	0.000402	0.00161	CcSEcCtD
Guanfacine—Chest pain—Docetaxel—skin cancer	0.000402	0.00161	CcSEcCtD
Guanfacine—Arthralgia—Docetaxel—skin cancer	0.000402	0.00161	CcSEcCtD
Guanfacine—Diarrhoea—Temozolomide—skin cancer	0.000396	0.00159	CcSEcCtD
Guanfacine—Hypersensitivity—Fluorouracil—skin cancer	0.000393	0.00158	CcSEcCtD
Guanfacine—Dry mouth—Docetaxel—skin cancer	0.000393	0.00158	CcSEcCtD
Guanfacine—Confusional state—Docetaxel—skin cancer	0.000389	0.00156	CcSEcCtD
Guanfacine—Oedema—Docetaxel—skin cancer	0.000385	0.00155	CcSEcCtD
Guanfacine—Dizziness—Temozolomide—skin cancer	0.000383	0.00154	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—skin cancer	0.000381	0.00153	CcSEcCtD
Guanfacine—Shock—Docetaxel—skin cancer	0.000379	0.00152	CcSEcCtD
Guanfacine—Pruritus—Fluorouracil—skin cancer	0.000378	0.00152	CcSEcCtD
Guanfacine—Tachycardia—Docetaxel—skin cancer	0.000376	0.00151	CcSEcCtD
Guanfacine—Vomiting—Temozolomide—skin cancer	0.000368	0.00148	CcSEcCtD
Guanfacine—Rash—Temozolomide—skin cancer	0.000365	0.00147	CcSEcCtD
Guanfacine—Diarrhoea—Fluorouracil—skin cancer	0.000365	0.00147	CcSEcCtD
Guanfacine—Dermatitis—Temozolomide—skin cancer	0.000365	0.00147	CcSEcCtD
Guanfacine—Headache—Temozolomide—skin cancer	0.000363	0.00146	CcSEcCtD
Guanfacine—Hypotension—Docetaxel—skin cancer	0.00036	0.00145	CcSEcCtD
Guanfacine—Dizziness—Fluorouracil—skin cancer	0.000353	0.00142	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000351	0.00141	CcSEcCtD
Guanfacine—Insomnia—Docetaxel—skin cancer	0.000349	0.0014	CcSEcCtD
Guanfacine—Paraesthesia—Docetaxel—skin cancer	0.000346	0.00139	CcSEcCtD
Guanfacine—Nausea—Temozolomide—skin cancer	0.000344	0.00138	CcSEcCtD
Guanfacine—Dyspnoea—Docetaxel—skin cancer	0.000344	0.00138	CcSEcCtD
Guanfacine—Somnolence—Docetaxel—skin cancer	0.000343	0.00138	CcSEcCtD
Guanfacine—Vomiting—Fluorouracil—skin cancer	0.000339	0.00136	CcSEcCtD
Guanfacine—Dyspepsia—Docetaxel—skin cancer	0.000339	0.00136	CcSEcCtD
Guanfacine—Rash—Fluorouracil—skin cancer	0.000337	0.00135	CcSEcCtD
Guanfacine—Dermatitis—Fluorouracil—skin cancer	0.000336	0.00135	CcSEcCtD
Guanfacine—Decreased appetite—Docetaxel—skin cancer	0.000335	0.00134	CcSEcCtD
Guanfacine—Headache—Fluorouracil—skin cancer	0.000334	0.00134	CcSEcCtD
Guanfacine—Fatigue—Docetaxel—skin cancer	0.000332	0.00133	CcSEcCtD
Guanfacine—Constipation—Docetaxel—skin cancer	0.00033	0.00132	CcSEcCtD
Guanfacine—Feeling abnormal—Docetaxel—skin cancer	0.000318	0.00127	CcSEcCtD
Guanfacine—Nausea—Fluorouracil—skin cancer	0.000317	0.00127	CcSEcCtD
Guanfacine—Gastrointestinal pain—Docetaxel—skin cancer	0.000315	0.00127	CcSEcCtD
Guanfacine—Abdominal pain—Docetaxel—skin cancer	0.000305	0.00122	CcSEcCtD
Guanfacine—Hypersensitivity—Docetaxel—skin cancer	0.000284	0.00114	CcSEcCtD
Guanfacine—Asthenia—Docetaxel—skin cancer	0.000276	0.00111	CcSEcCtD
Guanfacine—Pruritus—Docetaxel—skin cancer	0.000273	0.00109	CcSEcCtD
Guanfacine—Diarrhoea—Docetaxel—skin cancer	0.000264	0.00106	CcSEcCtD
Guanfacine—Dizziness—Docetaxel—skin cancer	0.000255	0.00102	CcSEcCtD
Guanfacine—Vomiting—Docetaxel—skin cancer	0.000245	0.000984	CcSEcCtD
Guanfacine—Rash—Docetaxel—skin cancer	0.000243	0.000975	CcSEcCtD
Guanfacine—Dermatitis—Docetaxel—skin cancer	0.000243	0.000975	CcSEcCtD
Guanfacine—Headache—Docetaxel—skin cancer	0.000241	0.000969	CcSEcCtD
Guanfacine—Nausea—Docetaxel—skin cancer	0.000229	0.000919	CcSEcCtD
